Profile for Nymox Pharmaceutical Corporation (NYMX)
« Back to company indexNYMX Chatter Timeline
Stock Ticker for NYMX
Most Active Tweeters for NYMX
| User | Tweets |
|---|---|
| @starfcker69 | 2 |
| @registrarjourn | 1 |
| @TheMarketsDaily | 1 |
| @OlympiaReport | 1 |
| @pennyomegaCRWE | 1 |
Recent Tweets for NYMX
 |
@biotechtoreador LOL $NYMX….https://t.co/UdnH5HLirQ May 25th 2018, 3:05pm |
 |
@starfcker69 $NYMX 11 international patent applications published in the last 6 months. https://t.co/97Wwlc6XOc May 24th 2018, 7:05pm |
 |
@Briefingcom $NYMX: Nymox Pharma discussed its lead product candidate Fexapotide Triflutate (FT) as a novel therapeutic option i… https://t.co/l7H2Uf9Nge May 22nd 2018, 12:05pm |
 |
@stocknewsdotcom $NYMX Company discussed its lead product candidate Fexapotide Triflutate (FT) as a novel therapeutic option in BPH… https://t.co/wYurqoES3D May 22nd 2018, 10:05am |
 |
@GNWLive Fexapotide Triflutate Pivotal Phase 3 Study Results Presented and Discussed at American Urological $NYMX https://t.co/jMghq01Y8x May 22nd 2018, 10:05am |
 |
@stockelite $NYMX Fexapotide Triflutate Pivotal Phase 3 Study Results Presented and Discussed at American Urological Associatio… https://t.co/c3MG5KbPTM May 22nd 2018, 10:05am |
|
@starfcker69 $NYMX update on European approval and US NDA "by end of 3rd quarter." Third quarter starts in 40 days. May 21st 2018, 9:05pm |
 |
@confcalltran Nymox Pharmaceutical: Quarterly Report For The Quarter Ended https://t.co/w5Ildo3nE4 $NYMX May 16th 2018, 7:05am |
 |
@OlympiaReport Head to Head Analysis: Oxford Immunotec Global $OXFD and Nymox Pharmaceutical $NYMX https://t.co/WGXC1RNB41 May 15th 2018, 3:05pm |
 |
@registrarjourn Head to Head Analysis: Oxford Immunotec Global $OXFD and Nymox Pharmaceutical $NYMX https://t.co/nGFNwx2MlZ May 15th 2018, 11:05am |
 |
@pennyomegaCRWE $NYMX 's Fexapotide Featured in Broadcast of Grand Rounds in Urology https://t.co/Bv6VsslCvv May 13th 2018, 6:05pm |
 |
@TheMarketsDaily Nymox Pharmaceutical $NYMX Earns Media Impact Rating of -0.04 https://t.co/WKItbT7VBM May 13th 2018, 12:05pm |
 |
@ThisLincolnian Nymox Pharmaceutical $NYMX Earns Media Impact Rating of -0.04 https://t.co/cnxifHtFu3 May 13th 2018, 12:05pm |
 |
@dispatchtribune Analyzing Nymox Pharmaceutical $NYMX & Oxford Immunotec Global $OXFD https://t.co/TCdmxbEIfK May 13th 2018, 10:05am |
|
@starfcker69 $NYMX as per the newly released annual report, insiders own 45.7% of the outstanding shares. May 11th 2018, 6:05pm |
 |
@JohnCappello (video) Physicians present persistent results of single ijection of Fexapotide from $NYMX for the treatment of BPH https://t.co/mRYA59jEUO May 11th 2018, 2:05pm |
|
@stockelite $NYMX Nymox’s Fexapotide Featured in Broadcast of Grand Rounds in Urology https://t.co/idnBTrAc2R May 11th 2018, 9:05am |
|
@GNWLive Nymox’s Fexapotide Featured in Broadcast of Grand Rounds in Urology $NYMX https://t.co/YLbXNWWlJX May 11th 2018, 9:05am |
 |
@ledgerzette Reviewing Nymox Pharmaceutical $NYMX and Oxford Immunotec Global $OXFD https://t.co/em0eEIkLRP May 11th 2018, 6:05am |
 |
@TickerReport Nymox Pharmaceutical $NYMX and Oxford Immunotec Global $OXFD Head-To-Head Survey https://t.co/uDzGIzt2yx May 11th 2018, 3:05am |
|
@TickerReport Nymox Pharmaceutical $NYMX and Oxford Immunotec Global $OXFD Head-To-Head Survey https://t.co/HvRlPTMC7c May 11th 2018, 2:05am |
 |
@EnterpriseLeade Financial Survey: Quidel $QDEL and Nymox Pharmaceutical $NYMX https://t.co/8GR0XTrG17 May 10th 2018, 5:05pm |
 |
@TranscriptDaily Financial Survey: Quidel $QDEL and Nymox Pharmaceutical $NYMX https://t.co/11SjZR3xkK May 10th 2018, 5:05pm |
 |
@WeekHerald Financial Survey: Quidel $QDEL and Nymox Pharmaceutical $NYMX https://t.co/5QA0WbdVsA May 10th 2018, 4:05pm |
 |
@FrankADeluca $NYMX Moved to Switzerland hummmm...Financial windfall engineering ? May 9th 2018, 10:05am |
|
@starfcker69 $NYMX 1 of 3 https://t.co/89o3lFYu6z May 8th 2018, 7:05pm |
 |
@ConsumerFeed Nymox Pharmaceutical $NYMX versus Oxford Immunotec Global $OXFD Head-To-Head Review https://t.co/eLLScrBwlW May 8th 2018, 5:05pm |
 |
@AmericanBanking Nymox Pharmaceutical $NYMX versus Oxford Immunotec Global $OXFD Head-To-Head Review https://t.co/Iy62FyaOEO #stocks May 8th 2018, 5:05pm |
|
@TickerReport Head to Head Contrast: Quidel $QDEL vs. Nymox Pharmaceutical $NYMX https://t.co/A94w06YtAJ May 8th 2018, 4:05pm |
|
@TranscriptDaily Nymox Pharmaceutical $NYMX Given Daily News Sentiment Rating of -0.02 https://t.co/zNm6OyDNrn May 8th 2018, 3:05pm |
 |
@PENNYBUSTER1 RT @MaisaCorp: $NYMX Announces Relocation Of Company Headquarters To Switzerland (FROM NASSAU, BAHAMAS TO ZUG IN SWITZERLAND) May 7th 2018, 3:05pm |
 |
@MaisaCorp $NYMX Announces Relocation Of Company Headquarters To Switzerland (FROM NASSAU, BAHAMAS TO ZUG IN SWITZERLAND) May 7th 2018, 3:05pm |
|
@starfcker69 $NYMX BREAKING NEWS: THINGS HAPPENED IN 2014 May 7th 2018, 1:05pm |
|
@starfcker69 $NYMX this move makes me think Averback is putting Danielsen in charge or setting him up to become CEO. May 7th 2018, 11:05am |
 |
@ProTrader_Mike $BLNK and $NYMX winners in big way #mojo #chatroom https://t.co/bD9dQ7BRK9 May 7th 2018, 10:05am |
|
@starfcker69 $NYMX I'm gonna miss all the "Bahama Scam" posts. May 7th 2018, 10:05am |
 |
@AlertTrade MOST ACTIVE ALERT: $NYMX NYMOX PHARMACEUTICALS ? TradeIdeas via https://t.co/VS8RO1bzXJ to Free Trading Room May 7th 2018, 10:05am |
|
@GNWLive Nymox Announces Relocation of Company Headquarters to Switzerland $NYMX https://t.co/FwY24njhKP May 7th 2018, 9:05am |
|
@dakotafinancial Nymox Pharmaceutical $NYMX Receives Media Impact Rating of -0.02 https://t.co/TEOnjQCr4Y May 3rd 2018, 11:05pm |
|
@dakotafinancial Analyzing Nymox Pharmaceutical $NYMX & Oxford Immunotec Global $OXFD https://t.co/oX1Y8NsX8z May 3rd 2018, 10:05pm |
|
@TheMarketsDaily Head-To-Head Review: Nymox Pharmaceutical $NYMX & Oxford Immunotec Global $OXFD https://t.co/Iqh0Uieh5o May 3rd 2018, 10:05pm |
|
@registrarjourn Analyzing Nymox Pharmaceutical $NYMX & Oxford Immunotec Global $OXFD https://t.co/MqFoA2MXDn May 3rd 2018, 3:05pm |
 |
@WatchlistN Analyzing Nymox Pharmaceutical $NYMX and Quidel $QDEL https://t.co/H9jEABBMhC May 3rd 2018, 12:05pm |
|
@registrarjourn Nymox Pharmaceutical $NYMX Receives Daily Media Impact Score of -0.02 https://t.co/xL1sRfdTIr May 3rd 2018, 12:05pm |
 |
@bdailystocks $NYMX $4.06 USD +0.040 (1.00% - News Out on Nymox Pharmaceutical https://t.co/nPQciwolN7 May 2nd 2018, 5:05pm |
 |
@StockTexts $NYMX Nymox Announces Fexapotide Drug Symposium at AUA Annual Meeting San Francisco May 20 Nasdaq:NYMX https://t.co/arpZxEJ6DU May 2nd 2018, 9:05am |
|
@stockelite $NYMX Nymox Announces Fexapotide Drug Symposium at AUA Annual Meeting San Francisco May 20 https://t.co/Gaghmgr35t May 2nd 2018, 9:05am |
|
@GNWLive Nymox Announces Fexapotide Drug Symposium at AUA Annual Meeting San Francisco May 20 $NYMX https://t.co/gqs83sJADR May 2nd 2018, 9:05am |
|
@WatchlistN Financial Survey: Oxford Immunotec Global $OXFD vs. Nymox Pharmaceutical $NYMX https://t.co/GLsElAQwyy May 1st 2018, 4:05am |
 |
@ZolmaxNews Head-To-Head Contrast: Quidel $QDEL vs. Nymox Pharmaceutical $NYMX https://t.co/bJfRU3jkel April 30th 2018, 4:04pm |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.